Literature DB >> 20678989

In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.

Mikolaj Milewski1, Thirupathi Reddy Yerramreddy, Priyanka Ghosh, Peter A Crooks, Audra L Stinchcomb.   

Abstract

Microneedles (MN) are a useful tool for increasing skin permeability to xenobiotics. Previous research showed marked improvement in the percutaneous flux of naltrexone (NTX) hydrochloride by the use of MN skin pretreatment alone; however, for better therapeutic effect, further enhancement is desired. The goal of this in vitro study was to combine microneedle skin pretreatment with the use of a highly water-soluble PEGylated naltrexone prodrug (polyethyleneglycol-NTX, PEG-NTX) to investigate its transdermal transport at varying concentrations. Solubility and stability of the prodrug were investigated. In vitro diffusion experiments employing MN-treated minipig skin were used to evaluate the performance of the PEGylated prodrug. The results revealed substantial deviation from ideal behavior, with the flux through MN-treated skin having a nonlinear relationship to the prodrug concentration in the donor solution. While in the lower concentration range tested the prodrug flux increase was proportional to the concentration increase, at high concentrations it showed no such dependence. Accounting for the decrease in the effective prodrug diffusivity accompanying the increase in viscosity, as predicted by the Stokes-Einstein equation, provided a rationale for the observed flux values. Increasing the viscosity of the donor solution is hypothesized to afford a curvilinear permeation profile for the PEGylated NTX prodrug. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678989      PMCID: PMC2916235          DOI: 10.1016/j.jconrel.2010.05.034

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  41 in total

Review 1.  Effect of pegylation on pharmaceuticals.

Authors:  J Milton Harris; Robert B Chess
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

2.  Comparison of two porcine (Sus scrofa domestica) skin models for in vivo near-infrared laser exposure.

Authors:  T A Eggleston; W P Roach; M A Mitchell; K Smith; D Oler; T E Johnson
Journal:  Comp Med       Date:  2000-08       Impact factor: 0.982

3.  Assessment of skin viability: is it necessary to use different methodologies?

Authors:  Syndie Messager; A C Hann; P A Goddard; P W Dettmar; J Y Maillard
Journal:  Skin Res Technol       Date:  2003-11       Impact factor: 2.365

Review 4.  The stratum corneum: structure and function in health and disease.

Authors:  Clive R Harding
Journal:  Dermatol Ther       Date:  2004       Impact factor: 2.851

Review 5.  Barrier function of the skin: "la raison d'être" of the epidermis.

Authors:  Kathi C Madison
Journal:  J Invest Dermatol       Date:  2003-08       Impact factor: 8.551

6.  The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide.

Authors:  R J Babu; N Kanikkannan; L Kikwai; C Ortega; S Andega; K Ball; S Yim; M Singh
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

Review 7.  Current status and future potential of transdermal drug delivery.

Authors:  Mark R Prausnitz; Samir Mitragotri; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2004-02       Impact factor: 84.694

8.  Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.

Authors:  Mikolaj Milewski; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2010-06-25       Impact factor: 4.200

9.  Percutaneous permeation and skin irritation of JP-8+100 jet fuel in a porcine model.

Authors:  N Kanikkannan; S Burton; R Patel; T Jackson; M S Shaik; M Singh
Journal:  Toxicol Lett       Date:  2001-02-28       Impact factor: 4.372

10.  Habituating pigs for in-pen, non-invasive biophysical skin analysis.

Authors:  R P Chilcott; B Stubbs; Z Ashley
Journal:  Lab Anim       Date:  2001-07       Impact factor: 2.471

View more
  14 in total

1.  Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.

Authors:  Thirupathi Reddy Yerramreddy; Mikolaj Milewski; Narsimha Reddy Penthala; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

2.  Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.

Authors:  Susruta Majumdar; Maren Mueller-Spaeth; Kenneth B Sloan
Journal:  AAPS PharmSciTech       Date:  2012-05-31       Impact factor: 3.246

3.  Enhanced skin delivery of vismodegib by microneedle treatment.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

4.  Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.

Authors:  Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

5.  Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.

Authors:  Punit P Shah; Pinaki R Desai; Mandip Singh
Journal:  J Control Release       Date:  2011-11-21       Impact factor: 9.776

6.  Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.

Authors:  Joshua A Eldridge; Mikolaj Milewski; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2014-10-02       Impact factor: 2.823

7.  Stability, cutaneous delivery, and antioxidant potential of a lipoic acid and α-tocopherol codrug incorporated in microemulsions.

Authors:  Siji Thomas; Camila S Vieira; Martha A Hass; Luciana B Lopes
Journal:  J Pharm Sci       Date:  2014-06-24       Impact factor: 3.534

8.  Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.

Authors:  Priyanka Ghosh; Nicole K Brogden; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-05-13       Impact factor: 4.939

9.  Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.

Authors:  Priyanka Ghosh; DoMin Lee; Kyung Bo Kim; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

Review 10.  Microneedles for drug and vaccine delivery.

Authors:  Yeu-Chun Kim; Jung-Hwan Park; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2012-05-01       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.